Marvel Biosciences Corp. (TSXV:MRVL)
Canada · Delayed Price · Currency is CAD 0.1350
+0.0150 (12.50%)
At close: Feb 27, 2026
Marvel Biosciences Market Cap
Marvel Biosciences has a market cap or net worth of CAD 7.83 million as of March 2, 2026. Its market cap has increased by 12.76% in one year.
Market Cap
7.83M
Enterprise Value
9.51M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.14
Market Cap Chart
Since July 13, 2021, Marvel Biosciences's market cap has decreased from 12.71M to 7.83M, a decrease of -38.38%. That is a compound annual growth rate of -9.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 7.83M | - |
| Dec 31, 2025 | 7.83M | 2.85% |
| Dec 31, 2024 | 7.61M | 139.21% |
| Dec 29, 2023 | 3.18M | -36.00% |
| Dec 30, 2022 | 4.97M | -43.47% |
| Dec 30, 2021 | 8.80M | -30.77% |
| Jul 13, 2021 | 12.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glow Lifetech | 9.08M |
| COSCIENS Biopharma | 8.02M |
| PharmaTher Holdings | 7.28M |
| Kane Biotech | 7.26M |
| BioVaxys Technology | 6.83M |
| Cytophage Technologies | 6.43M |
| Restart Life Sciences | 5.93M |
| Aptose Biosciences | 5.51M |